Compare Organon Pharma Indonesia Tbk. (SCPI) vs Damai Sejahtera Abadi Tbk. (UFOE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Damai Sejahtera Abadi Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Damai Sejahtera Abadi Tbk. trades at Rp145 (market cap 423.15B, 5.35M 24h volume). The key difference: Damai Sejahtera Abadi Tbk. is far larger — about 4.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | UFOE | |
|---|---|---|
Market Cap | 104.4B | 423.15B |
Volume | — | 5.35M |
Lot | — | 53.47K |
Turnover | — | 805.82M |
Average Price | — | 150.7 |
Value | — | 805.82M |
Indicative Equilibrium Price | — | 145 |
Indicative Equilibrium Volume | — | 277 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Damai Sejahtera Abadi Tbk.
PT Damai Sejahtera Abadi Tbk (the Company) was established in Surabaya based on Notarial Deed No. 46 of Setiawati Sabarudin, S.H., Notary in Surabaya, dated January 29, 2004. The Company’s immediate parent company is PT Damai Sejahtera Lestari, which is ultimately owned by Mr. Pudji Harianto and Mr. Poedji Harixon.
Read more on UFOE →
